Translational Validation of Personalized Treatment Strategy Based on Genetic Characteristics of Glioblastoma

• Young Taek Oh,

  Affiliations Samsung Biomedical Research Institute, Samsung Medical Center, Seoul, Korea, Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea, Samsung Advanced Institute for Health Sciences and Technology (SAIHST), Sungkyunkwan University, Seoul, Korea

  ⨯
• Hee Jin Cho,

  Affiliations Samsung Biomedical Research Institute, Samsung Medical Center, Seoul, Korea, Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea, Samsung Advanced Institute for Health Sciences and Technology (SAIHST), Sungkyunkwan University, Seoul, Korea

  ⨯
• Jinkuk Kim,

  Affiliations Samsung Biomedical Research Institute, Samsung Medical Center, Seoul, Korea, Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea, Samsung Advanced Institute of Technology, Samsung Electronics Co., Ltd., Seoul, Korea

  ⨯
• Ji-Hyun Lee,

  Affiliation Medicinal Bioconvergence Research Center, College of Pharmacy, Seoul National University, Seoul, Korea

  ⨯
• Kyoohyoung Rho,

  Affiliation Medicinal Bioconvergence Research Center, College of Pharmacy, Seoul National University, Seoul, Korea

  ⨯
• Yun-Jee Seo,

  Affiliations Samsung Biomedical Research Institute, Samsung Medical Center, Seoul, Korea, Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea

  ⨯
• Yeon-Sook Choi,

  Affiliations Samsung Biomedical Research Institute, Samsung Medical Center, Seoul, Korea, Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea

  ⨯
• Hye Jin Jung,

  Affiliations Samsung Biomedical Research Institute, Samsung Medical Center, Seoul, Korea, Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea

  ⨯
• Hyeon Suk Song,

  Affiliations Samsung Biomedical Research Institute, Samsung Medical Center, Seoul, Korea, Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea

  ⨯
• Doo-Sik Kong,

  Affiliations Samsung Biomedical Research Institute, Samsung Medical Center, Seoul, Korea, Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea, Department of Neurosurgery, School of Medicine, Sungkyunkwan University, Seoul, Korea

  ⨯
• Ho Jun Seol,

  Affiliations Samsung Biomedical Research Institute, Samsung Medical Center, Seoul, Korea, Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea, Department of Neurosurgery, School of Medicine, Sungkyunkwan University, Seoul, Korea

  ⨯
• Jung-Il Lee,

  Affiliations Samsung Biomedical Research Institute, Samsung Medical Center, Seoul, Korea, Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea, Department of Neurosurgery, School of Medicine, Sungkyunkwan University, Seoul, Korea

  ⨯
• Yeup Yoon,

  Affiliations Samsung Biomedical Research Institute, Samsung Medical Center, Seoul, Korea, Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea, Samsung Advanced Institute for Health Sciences and Technology (SAIHST), Sungkyunkwan University, Seoul, Korea

  ⨯
• Sunghoon Kim ,

  * E-mail: sungkim@snu.ac.kr (SHK); nsnam@skku.edu (DHN); kmjoo@skku.edu (KMJ)

  Affiliation Medicinal Bioconvergence Research Center, College of Pharmacy, Seoul National University, Seoul, Korea

  ⨯
• Do-Hyun Nam ,

  * E-mail: sungkim@snu.ac.kr (SHK); nsnam@skku.edu (DHN); kmjoo@skku.edu (KMJ)

  Affiliations Samsung Biomedical Research Institute, Samsung Medical Center, Seoul, Korea, Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea, Samsung Advanced Institute for Health Sciences and Technology (SAIHST), Sungkyunkwan University, Seoul, Korea, Department of Neurosurgery, School of Medicine, Sungkyunkwan University, Seoul, Korea

  ⨯
•  [ ... ],
• Kyeung Min Joo

  * E-mail: sungkim@snu.ac.kr (SHK); nsnam@skku.edu (DHN); kmjoo@skku.edu (KMJ)

  Affiliations Samsung Biomedical Research Institute, Samsung Medical Center, Seoul, Korea, Institute for Refractory Cancer Research, Samsung Medical Center, Seoul, Korea, Samsung Advanced Institute for Health Sciences and Technology (SAIHST), Sungkyunkwan University, Seoul, Korea, Department of Anatomy and Cell Biology, School of Medicine, Sungkyunkwan University, Seoul, Korea

  ⨯
• [ view all ]
• [ view less ]